A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/24 (2006.01) A61K 31/138 (2006.01)
Patent
CA 2457851
The invention provides a protocol leading to improved embryo implantation rates and/or decreased miscarriage rates in which hCG or LH, or a bio-analogue thereof, is administered during the follicular phase.
L'invention porte sur un protocole entraînant des taux améliorés d'implantation des embryons et/ou à une baisse des fausses couches, et selon lequel on administre pendant la phase folliculaire de l'hCG ou de la LH, ou l'un de leurs bio-analogues.
Applied Research Systems Ars Holding N.v.
Borden Ladner Gervais Llp
Merck Serono Sa
LandOfFree
Use of hcg and lh in controlled ovarian hyperstimulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of hcg and lh in controlled ovarian hyperstimulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of hcg and lh in controlled ovarian hyperstimulation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1984809